# Trevi Therapeutics, Inc.: Form 8-K, filed Oct 4, 2024

- Company: [Trevi Therapeutics, Inc.](/companies/trvi.md) (CIK 1563880)
- Form: 8-K
- Filed: 2024-10-04
- Accepted by EDGAR: Oct 4, 2024, 08:07 ET
- Period: 2024-10-03
- Accession: 0000950170-24-112729
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1563880/000095017024112729/trvi-20241003.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1563880/000095017024112729/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1563880/000095017024112729/trvi-20241003.htm

Filed Oct 4, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-112729. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.